Edition:
United States

AMAG Pharmaceuticals Inc (AMAG.OQ)

AMAG.OQ on NASDAQ Stock Exchange Global Select Market

23.20USD
4:00pm EDT
Change (% chg)

$0.80 (+3.57%)
Prev Close
$22.40
Open
$22.70
Day's High
$23.60
Day's Low
$22.65
Volume
194,186
Avg. Vol
261,473
52-wk High
$36.80
52-wk Low
$17.94

AMAG.OQ

Chart for AMAG.OQ

About

AMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia... (more)

Overall

Beta: 1.09
Market Cap(Mil.): $771.58
Shares Outstanding(Mil.): 34.45
Dividend: --
Yield (%): --

Financials

  AMAG.OQ Industry Sector
P/E (TTM): -- 29.08 29.95
EPS (TTM): -0.16 -- --
ROI: -0.11 13.66 13.21
ROE: -0.27 14.61 14.38

BRIEF-Amag submits supplemental NDA for makena auto-injector

* Amag submits supplemental new drug application to FDA for makena (hydroxyprogesterone caproate injection) auto-injector for subcutaneous use

Apr 17 2017

BRIEF-Amag Pharmaceuticals, Endoceutics enter into license agreement

* Amag and Endoceutics enter into an exclusive U.S. license agreement for intrarosa (prasterone)

Feb 14 2017

BRIEF-Amag Pharmaceuticals sees Q4 2016 revenue $150 mln to $155 mln

* AMAG Pharmaceuticals provides financial and business update

Jan 09 2017

BRIEF-Amag Pharmaceuticals enters into an agreement to develop and commercialize Rekynda

* Entered into an agreement for exclusive North American rights to develop and commercialize Rekynda

Jan 09 2017

BRIEF-Amag Pharma Q3 earnings per share $0.43

* Amag pharmaceuticals reports third quarter 2016 financial results and provides corporate update

Nov 03 2016

More From Around the Web

Competitors

Earnings vs. Estimates